Human gingiva-derived mesenchymal stromal cells inhibit graft-versus-host disease through CD39 and IDO (THER5P.844)

song guo zheng,maogen chen,julie wang,nancy j olsen

DOI: https://doi.org/10.4049/jimmunol.192.supp.200.23

2014-01-01

Abstract:Mesenchymal stem cells have the capacity to maintain immune homeostasis and prevent autoimmunity. We recently reported that human-derived gingival mesenchymal stem cells (GMSCs) have strong capacity to suppress immune responses and T cell-mediated collagen-induced arthritis in animals. However, it is unclear whether these cells can suppress human T cell-mediated diseases. Here, we used a xeno-GVHD model to investigate the interventional role of human GMSCs in NOD/SCID mouse, which is a best animal model to study human cell therapy prior to a clinical trial. We found that GMSCs potently suppressed the proliferation of PBMC and T cells in vitro. Co-transfer of GMSC and human PBMC significantly prolonged the mouse survival. Moreover, we demonstrated that GMSCs inhibited human PBMCs-initiated xenogenic responses via CD39 and IDO signals. Thus, GMSCs can suppress human immune responses and immune system-mediated diseases, offering a potential clinical option to be used for modulating GVHD and other autoimmune diseases.